fda approved tirzepatide approves weight-loss drug Zepbound to treat sleep apnea – San Diego Union-Tribune FDA approves new version of

The glucagon-like peptide-1 (GLP-1) receptor agonists are well-known for causing stomach side effects, but these are typically tolerable and short-term for most people

Peak weight loss generally occurs between 60-72 weeks of treatment

Theres been a revolving door of viral social media posts recently promoting the idea that youll boost your chances of conceiving if you take GLP-1 weight-loss medications

Mazdutide is another newer option, and the mazdutide versus tirzepatide comparison covers the differences in mechanism and early efficacy data

Re-escalation to 2.4 mg once weekly may be considered if the lower dose is tolerated